purchase customization

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sterile Insulin Syringe
1.2.3 Pre-Filled Syringe
1.2.4 Infusion Bags
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Luxturna
1.3.3 Kymriah
1.3.4 Provenge
1.3.5 Zolgensma
1.3.6 Yescarta
1.3.7 Strimvelis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region
2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends
2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2021
3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type
4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application
5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen, Inc.
11.1.1 Amgen, Inc. Company Details
11.1.2 Amgen, Inc. Business Overview
11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.1.5 Amgen, Inc. Recent Developments
11.2 Bausch and Lomb Incorporated
11.2.1 Bausch and Lomb Incorporated Company Details
11.2.2 Bausch and Lomb Incorporated Business Overview
11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.2.5 Bausch and Lomb Incorporated Recent Developments
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Developments
11.4 Bluebird bio, Inc.
11.4.1 Bluebird bio, Inc. Company Details
11.4.2 Bluebird bio, Inc. Business Overview
11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.4.5 Bluebird bio, Inc. Recent Developments
11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Dendreon Pharmaceuticals LLC. Company Details
11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.6.5 Dendreon Pharmaceuticals LLC. Recent Developments
11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments
11.8 Human Stem Cell Institute
11.8.1 Human Stem Cell Institute Company Details
11.8.2 Human Stem Cell Institute Business Overview
11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.8.5 Human Stem Cell Institute Recent Developments
11.9 Kite Pharma, Inc.
11.9.1 Kite Pharma, Inc. Company Details
11.9.2 Kite Pharma, Inc. Business Overview
11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.9.5 Kite Pharma, Inc. Recent Developments
11.10 Kolon Tissue Gene, inc.
11.10.1 Kolon Tissue Gene, inc. Company Details
11.10.2 Kolon Tissue Gene, inc. Business Overview
11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.10.5 Kolon Tissue Gene, inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.11.5 Novartis AG Recent Developments
11.12 Orchard Therapeutics plc.
11.12.1 Orchard Therapeutics plc. Company Details
11.12.2 Orchard Therapeutics plc. Business Overview
11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.12.5 Orchard Therapeutics plc. Recent Developments
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.13.5 Pfizer, Inc. Recent Developments
11.14 Renova Therapeutics
11.14.1 Renova Therapeutics Company Details
11.14.2 Renova Therapeutics Business Overview
11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.14.5 Renova Therapeutics Recent Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.15.5 Spark Therapeutics, Inc. Recent Developments
11.16 uniQure N.V.
11.16.1 uniQure N.V. Company Details
11.16.2 uniQure N.V. Business Overview
11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.16.5 uniQure N.V. Recent Developments
11.17 Vericel Corporation
11.17.1 Vericel Corporation Company Details
11.17.2 Vericel Corporation Business Overview
11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2017-2022)
11.17.5 Vericel Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer